Interleukin-17 and Its Target Genes: Mechanisms of Interleukin-17 Function in Disease

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 2010 Apr 23

PMID 20409152

Citations 423

Authors

Reiko M Onishi

Sarah L Gaffen

Affiliations

Soon will be listed here.

Abstract

Interleukin-17 (IL-17) has emerged as a central player in the mammalian immune system. Although this cytokine exerts a host-defensive role in many infectious diseases, it promotes inflammatory pathology in autoimmunity and other settings. A myriad of studies have focused on how IL-17-producing cells are generated. However, the means by which IL-17 achieves its effects, either for the benefit or the detriment of the host, are due in large part to the induction of new gene expression. Whereas many IL-17 target genes are common to different disease states, in some cases the effects of IL-17 differ depending on the target cell, infectious site or pathogen. Gene products induced by IL-17 include cytokines (IL-6, granulocyte-colony-stimulating factor, tumour necrosis factor-alpha), chemokines (CXCL1, CXCL2, CCL20, among many others), inflammatory effectors (acute-phase protesins, complement) and antimicrobial proteins (defensins, mucins). Different cell types appear to respond differently to IL-17 in terms of target gene expression, with notable differences seen in mesenchymal and epithelial cells compared with cells of haematopoietic origin. Here, we summarize the major IL-17 target genes that mediate this cytokine's activities in both autoimmune and chronic diseases as well as during various types of infections.

Citing Articles

The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.

Zhang J, Shen M Clin Rev Allergy Immunol. 2025; 68(1):27.

PMID: 40074883 DOI: 10.1007/s12016-025-09042-5.

The RNA binding protein CARHSP1 facilitates tumor growth, metastasis and immune escape by enhancing IL-17RA mRNA stabilization in prostate cancer.

Jiang Y, Wang Y, Xue K, Ma J, Xu S, Wang K Cell Biosci. 2025; 15(1):33.

PMID: 40055805 PMC: 11889941. DOI: 10.1186/s13578-025-01371-4.

Associations Between Serum IL-17A, Renal Function and Diabetic Retinopathy in Type 2 Diabetes Mellitus: Evidence From a Chinese Han Population.

Wang W, Huang Y, Shen J, Jin L, Chen Z Endocrinol Diabetes Metab. 2025; 8(2):e70033.

PMID: 39946217 PMC: 11824365. DOI: 10.1002/edm2.70033.

Deciphering the role of IL17RA in psoriasis and chronic mucocutaneous candidiasis: shared pathways and distinct manifestations.

Kadhi A, Eid E, Massaad M, El-Rassy I, Khoury D, Shimomura Y Front Immunol. 2025; 15:1516408.

PMID: 39911581 PMC: 11796622. DOI: 10.3389/fimmu.2024.1516408.

The IL-23/Th17 pathway inhibitors in the treatment of psoriasis and the risk of skin malignancies: a review.

Krzysztofik M, Brzewski P, Kulbat A, Masajada M, Richter K, Wysocki W Postepy Dermatol Alergol. 2025; 41(6):552-559.

PMID: 39877117 PMC: 11770571. DOI: 10.5114/ada.2024.143428.

References

McGeachy M, Bak-Jensen K, Chen Y, Tato C, Blumenschein W, Mcclanahan T . TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007; 8(12):1390-7. DOI: 10.1038/ni1539. View

Cargill M, Schrodi S, Chang M, Garcia V, Brandon R, Callis K . A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007; 80(2):273-90. PMC: 1785338. DOI: 10.1086/511051. View

Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M . Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity. 2008; 29(4):628-36. DOI: 10.1016/j.immuni.2008.07.018. View

Brennan F, McInnes I . Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008; 118(11):3537-45. PMC: 2575731. DOI: 10.1172/JCI36389. View

Koenders M, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen M, Di Padova F . Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol. 2005; 167(1):141-9. PMC: 1603454. DOI: 10.1016/S0002-9440(10)62961-6. View

OConnor Jr W, Kamanaka M, Booth C, Town T, Nakae S, Iwakura Y . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603-9. PMC: 2709990. DOI: 10.1038/ni.1736. View

Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls J . Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006; 12(5):382-8. DOI: 10.1097/01.MIB.0000218764.06959.91. View

Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang Y, Homey B . Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007; 449(7162):564-9. DOI: 10.1038/nature06116. View

Conti H, Shen F, Nayyar N, Stocum E, Sun J, Lindemann M . Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009; 206(2):299-311. PMC: 2646568. DOI: 10.1084/jem.20081463. View

10.

Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y . Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol. 2004; 110(1):55-62. DOI: 10.1016/j.clim.2003.09.013. View

11.

Li X . Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine. 2007; 41(2):105-13. DOI: 10.1016/j.cyto.2007.09.015. View

12.

Nestle F, Kaplan D, Barker J . Psoriasis. N Engl J Med. 2009; 361(5):496-509. DOI: 10.1056/NEJMra0804595. View

13.

Aggarwal S, Gurney A . IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002; 71(1):1-8. View

14.

Dong C . TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008; 8(5):337-48. DOI: 10.1038/nri2295. View

15.

Lockhart E, Green A, Flynn J . IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006; 177(7):4662-9. DOI: 10.4049/jimmunol.177.7.4662. View

16.

Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna M, Hayashi H . IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol. 2007; 179(6):3917-25. DOI: 10.4049/jimmunol.179.6.3917. View

17.

Hsu H, Wu Y, Yang P, Wu Q, Job G, Chen J . Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol. 2007; 178(8):5357-65. DOI: 10.4049/jimmunol.178.8.5357. View

18.

Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho I . Ets-1 is a negative regulator of Th17 differentiation. J Exp Med. 2007; 204(12):2825-35. PMC: 2118518. DOI: 10.1084/jem.20070994. View

19.

Bluestone J, Mackay C, OShea J, Stockinger B . The functional plasticity of T cell subsets. Nat Rev Immunol. 2009; 9(11):811-6. PMC: 3075537. DOI: 10.1038/nri2654. View

20.

Qian Y, Liu C, Hartupee J, Altuntas C, Gulen M, Jane-Wit D . The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007; 8(3):247-56. DOI: 10.1038/ni1439. View